{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T09:28:50Z","timestamp":1792056530957,"version":"4.4.0"},"reference-count":24,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2020,5,1]]},"DOI":"10.1001\/jamadermatol.2020.0035","type":"journal-article","created":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T17:32:04Z","timestamp":1585762324000},"page":"521","source":"Crossref","is-referenced-by-count":42,"title":["Evaluation of the Effectiveness and Tolerability of Mycophenolate Mofetil and Mycophenolic Acid for the Treatment of Morphea"],"prefix":"10.1001","volume":"156","author":[{"given":"Megan","family":"Arthur","sequence":"first","affiliation":[{"name":"Department of Dermatology, University of Nebraska, Omaha"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole M.","family":"Fett","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Oregon Health & Science University, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emile","family":"Latour","sequence":"additional","affiliation":[{"name":"Biostatistics Shared Resource, Knight Cancer Institute, Oregon Health & Science University, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Jacobe","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Texas Southwestern, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Kunzler","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Texas Southwestern, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Florez-Pollack","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Texas Southwestern, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Houser","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Texas Southwestern, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivani","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Texas Southwestern, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smriti","family":"Prasad","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Texas Southwestern, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisa","family":"Femia","sequence":"additional","affiliation":[{"name":"Department of Dermatology, New York University Langone Medical Center, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marleigh J.","family":"Stern","sequence":"additional","affiliation":[{"name":"Department of Dermatology, New York University Langone Medical Center, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa K.","family":"Pappas-Taffer","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Gaffney","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony P.","family":"Fernandez","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Knabel","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adela Rambi","family":"Cardones","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Duke University, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Leung","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Duke University, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Laumann","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Northwestern University, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Min","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Northwestern University, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Northwestern University, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth Ann","family":"Vleugels","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Tkachenko","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Lo","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"2","key":"doi200004r1","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jaad.2010.05.045","article-title":"Update on morphea, part I: epidemiology, clinical presentation, and pathogenesis.","volume":"64","author":"Fett","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"doi200004r2","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jaad.2010.05.046","article-title":"Update on morphea, part II: outcome measures and treatment.","volume":"64","author":"Fett","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"doi200004r3","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.jaad.2010.09.006","article-title":"A systematic review of morphea treatments and therapeutic algorithm.","volume":"65","author":"Zwischenberger","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"doi200004r4","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.clindermatol.2013.01.010","article-title":"Scleroderma: nomenclature, etiology, pathogenesis, prognosis, and treatments: facts and controversies.","volume":"31","author":"Fett","year":"2013","journal-title":"Clin Dermatol"},{"issue":"8","key":"doi200004r5","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/acr.21687","article-title":"Development of consensus treatment plans for juvenile localized scleroderma: a roadmap toward comparative effectiveness studies in juvenile localized scleroderma.","volume":"64","author":"Li","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2","key":"doi200004r6","doi-asserted-by":"publisher","first-page":"135","DOI":"10.4103\/0378-6323.93628","article-title":"Morphea: evidence-based recommendations for treatment.","volume":"78","author":"Fett","year":"2012","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"7","key":"doi200004r7","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1002\/art.v63.7","article-title":"Methotrexate treatment in juvenile localized scleroderma: a randomized, double-blind, placebo-controlled trial.","volume":"63","author":"Zulian","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"4","key":"doi200004r8","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s11845-008-0217-0","article-title":"Juvenile localised scleroderma: a retrospective review of response to systemic treatment.","volume":"177","author":"Cox","year":"2008","journal-title":"Ir J Med Sci"},{"issue":"3","key":"doi200004r9","first-page":"609","article-title":"Treatment of pediatric localized scleroderma with methotrexate.","volume":"33","author":"Fitch","year":"2006","journal-title":"J Rheumatol"},{"issue":"1","key":"doi200004r10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0022-3476(00)90056-8","article-title":"Methotrexate and corticosteroid therapy for pediatric localized scleroderma.","volume":"136","author":"Uziel","year":"2000","journal-title":"J Pediatr"},{"issue":"5","key":"doi200004r11","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1111\/bjd.2006.155.issue-5","article-title":"Evaluation of methotrexate and corticosteroids for the treatment of localized scleroderma (morphoea) in children.","volume":"155","author":"Weibel","year":"2006","journal-title":"Br J Dermatol"},{"issue":"6","key":"doi200004r12","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.jaad.2012.03.036","article-title":"A long-term follow-up study of methotrexate in juvenile localized scleroderma (morphea).","volume":"67","author":"Zulian","year":"2012","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"doi200004r13","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.jaad.2008.05.005","article-title":"Pediatric morphea (localized scleroderma): review of 136 patients.","volume":"59","author":"Christen-Zaech","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"doi200004r14","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1001\/archderm.141.7.847","article-title":"Pulsed high-dose corticosteroids combined with low-dose methotrexate in severe localized scleroderma.","volume":"141","author":"Kreuter","year":"2005","journal-title":"Arch Dermatol"},{"issue":"5","key":"doi200004r15","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1111\/bjd.2009.160.issue-5","article-title":"Effectiveness, side-effects and period of remission after treatment with methotrexate in localized scleroderma and related sclerotic skin diseases: an inception cohort study.","volume":"160","author":"Kroft","year":"2009","journal-title":"Br J Dermatol"},{"issue":"12","key":"doi200004r16","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1093\/rheumatology\/kep295","article-title":"A prospective open-label study of mycophenolate mofetil for the treatment of diffuse systemic sclerosis.","volume":"48","author":"Derk","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"doi200004r17","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.3899\/jrheum.111229","article-title":"A prospective observational study of mycophenolate mofetil treatment in progressive diffuse cutaneous systemic sclerosis of recent onset.","volume":"39","author":"Mendoza","year":"2012","journal-title":"J Rheumatol"},{"issue":"1","key":"doi200004r18","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1093\/rheumatology\/40.1.84","article-title":"Pilot study of anti-thymocyte globulin plus mycophenolate mofetil in recent-onset diffuse scleroderma.","volume":"40","author":"Stratton","year":"2001","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"doi200004r19","first-page":"287","article-title":"A pilot study of mycophenolate mofetil combined to intravenous methylprednisolone pulses and oral low-dose glucocorticoids in severe early systemic sclerosis.","volume":"25","author":"Vanthuyne","year":"2007","journal-title":"Clin Exp Rheumatol"},{"issue":"11","key":"doi200004r20","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1093\/rheumatology\/kep244","article-title":"Successful treatment of severe or methotrexate-resistant juvenile localized scleroderma with mycophenolate mofetil.","volume":"48","author":"Martini","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"doi200004r21","doi-asserted-by":"publisher","first-page":"510","DOI":"10.2340\/00015555-2297","article-title":"Use of mycophenolate mofetil in patients with severe localized scleroderma resistant or intolerant to methotrexate.","volume":"96","author":"Mertens","year":"2016","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"doi200004r22","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/rheumatology\/kep361","article-title":"Development and initial validation of the localized scleroderma skin damage index and physician global assessment of disease damage: a proof-of-concept study.","volume":"49","author":"Arkachaisri","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"doi200004r24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124205","article-title":"Safety and effectiveness of mycophenolate in systemic sclerosis: a systematic review.","volume":"10","author":"Omair","year":"2015","journal-title":"PLoS One"},{"key":"doi200004r23","author":"R Core Team","year":"2014"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2763680\/jamadermatology_arthur_2020_oi_200004_1615922315.13898.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T07:19:21Z","timestamp":1722669561000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2763680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,1]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2020.0035","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5,1]]}}}